Medical Research Future Fund

• NCT07435636

  Collaborator, Phase 2, Not yet recruiting, 80 people, 27 Feb 2026

• Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment

  Collaborator, Completed, 42 people, 6 Sept 2022

• NCT05415267

  Collaborator, Phase 3, Recruiting, 320 people, 13 Jun 2022

Sources: clinicaltrials.gov

• Henry Broadaty

  2025 Dementia, Ageing and Aged Care, National implementation of an online intervention to improve quality of life and delay cognitive decline with ageing, MRF2048642, 2026–2031, 1 Apr 2026

• The University of New South Wales

  2025 Dementia, Ageing and Aged Care, National implementation of an online intervention to improve quality of life and delay cognitive decline with ageing, MRF2048642, A$3m, 2026–2031, 1 Apr 2026

• Sharon Naismith

  2024 Clinical Trials Activity, The effects of dual orexin receptor antagonists on cognition, neurodegeneration and sleep in Mild Cognitive Impairment: a feasibility RCT, MRF2046116, 2026–2028, 1 Mar 2026

• University of Sydney

  2024 Clinical Trials Activity, The effects of dual orexin receptor antagonists on cognition, neurodegeneration and sleep in Mild Cognitive Impairment: a feasibility RCT, MRF2046116, A$798.5k, 2026–2028, 1 Mar 2026

• Robert Sanders

  2024 Clinical Trials Activity, NSAID administration Or Theatre Benzodiazepine Avoidance for Delirium & Days Alive and at Home, MRF2045957, 2026–2028, 1 Mar 2026

• University of Sydney

  2024 Clinical Trials Activity, NSAID administration Or Theatre Benzodiazepine Avoidance for Delirium & Days Alive and at Home, MRF2045957, A$799.9k, 2026–2028, 1 Mar 2026

• David Lynn

  2024 Post-Acute Sequelae of COVID-19, An Experimental Medicine Approach to Understand the Mechanisms Underpinning the Post-Acute Sequelae of COVID-19, MRF2045888, 2025–2027, 1 Dec 2025

• Flinders University

  2024 Post-Acute Sequelae of COVID-19, An Experimental Medicine Approach to Understand the Mechanisms Underpinning the Post-Acute Sequelae of COVID-19, MRF2045888, A$995.3k, 2025–2027, 1 Dec 2025

• Kate Laver

  2024 Post-Acute Sequelae of COVID-19, RECOVER trial – Restoring Energy and Capacity in Older adults via Embedded Rehabilitation, MRF2046840, 2025–2029, 1 Dec 2025

• Flinders University

  2024 Post-Acute Sequelae of COVID-19, RECOVER trial – Restoring Energy and Capacity in Older adults via Embedded Rehabilitation, MRF2046840, A$2.1m, 2025–2029, 1 Dec 2025

• Laura Forrest

  2024 Genomics Health Futures, Testing the feasibility of PERSONA: a personalised breast and ovarian cancer risk assessment incorporating polygenic information that identifies high-risk women, MRF2045389, 2025–2027, 1 Jun 2025

• University of Melbourne

  2024 Genomics Health Futures, Testing the feasibility of PERSONA: a personalised breast and ovarian cancer risk assessment incorporating polygenic information that identifies high-risk women, MRF2045389, A$977k, 2025–2027, 1 Jun 2025

• Sibel Saya

  2024 Genomics Health Futures, ROSELLA: Implementation of polygenic risk assessment in general practice for Australia’s most common cancers, MRF2045030, 2025–2027, 1 Jun 2025

• University of Melbourne

  2024 Genomics Health Futures, ROSELLA: Implementation of polygenic risk assessment in general practice for Australia’s most common cancers, MRF2045030, A$984.2k, 2025–2027, 1 Jun 2025

• Mark Jenkins

  2024 Genomics Health Futures, CRISP Alliance: Enhancing Polygenic Risk Scores with Proteomics for Colorectal Cancer Surveillance and Prediction, MRF2045162, 2025–2027, 1 Jun 2025

• University of Melbourne

  2024 Genomics Health Futures, CRISP Alliance: Enhancing Polygenic Risk Scores with Proteomics for Colorectal Cancer Surveillance and Prediction, MRF2045162, A$983.1k, 2025–2027, 1 Jun 2025

• Wanyuan Cui

  2024 Infertility, Pregnancy Loss and Menopause, The FERTILE Study: Evaluating ovarian toxicity Outcomes Following Immunotherapy in Triple-Negative Breast Cancer (TNBC), MRF2044521, 2025–2028, 1 Jun 2025

• University of Melbourne

  2024 Infertility, Pregnancy Loss and Menopause, The FERTILE Study: Evaluating ovarian toxicity Outcomes Following Immunotherapy in Triple-Negative Breast Cancer (TNBC), MRF2044521, A$652.5k, 2025–2028, 1 Jun 2025

• Sandra Richardson

  2024 Infertility, Pregnancy Loss and Menopause, A role for mobile DNA in unexplained female infertility, MRF2043804, 2025–2028, 1 Jun 2025

• University of Queensland

  2024 Infertility, Pregnancy Loss and Menopause, A role for mobile DNA in unexplained female infertility, MRF2043804, A$785.8k, 2025–2028, 1 Jun 2025

Sources: openalex.org

• Embedding smoking cessation into lung cancer screening: Priorities of national expert stakeholders in Australia using a modified nominal group technique

  2008603, 26 Sept 2026

• Motor speech markers of Alzheimer's risk

  MRFF1170820, 26 Sept 2026

• A Genome-wide Genetic Data Resource for the 45 and Up Study

  2007708, 22 Sept 2026

• Cardiovascular risk management through a community-based digital health stroke education platform (Love Your Brain): a multi-arm randomized controlled trial

  Love Your Brain; 2015976, 22 Sept 2026

• Association of long-term care facility ownership and location on residents' mortality and hospitalisations: A population-based retrospective cohort study in Australia

  2021-2024 PHRDI000009, 2024-2029 NCRI000109, PHRDI000009, 20 Sept 2026

• Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial

  4 Sept 2026

• Psychosocial, Mental, and Suboptimal Health Measures Are Not Affected by Provision of Abdominal Aortic Calcification Imaging Results: A 12-Week RCT

  APP1199751, APP1199751 (2020-2023), 9 May 2026

Sources: api.crossref.org

• Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial

  Fees or honoraria, Grants or research support, 29 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study

  EClinicalMedicine, 1 Sept 2026

• Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men : Individual Participant Data Meta-analyses

  Annals of internal medicine, 14 May 2024